From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 9,846,000 shares, representing 2.19% for $304.77 million under the buyback announced on March 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.65 USD | -0.45% |
|
+3.66% | -5.13% |
07-01 | Royalty Pharma plc(NasdaqGS:RPRX) added to Russell 1000 Defensive Index | CI |
07-01 | Royalty Pharma plc(NasdaqGS:RPRX) added to Russell 1000 Value-Defensive Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.13% | 12.05B | |
+63.05% | 856B | |
+38.86% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.72% | 244B | |
+5.03% | 234B | |
+16.33% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023.